State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 937,952 shares of common stock in Idaho Strategic Resources Inc, representing 5.9% of the class, based on a triggering event dated September 30, 2026.
Yinan Ren filed Amendment No. 2 to a Schedule 13D with the SEC on November 10, 2026, disclosing an open-market purchase of 150,000 Class A Ordinary Shares of YYForce Inc. on November 9, 2026, and reporting aggregate beneficial ownership of 3,937,379 shares.
Westrock Coffee Company filed a Form S-3 registration statement with the SEC on November 10, 2026, registering up to $500,000,000 in securities on a delayed or continuous basis as a replacement for its prior shelf registration statement.
AST SpaceMobile, Inc. filed a Form 8-K on November 10, 2026, disclosing a press release issued November 9, 2026, announcing that Rakuten and AST SpaceMobile have established a joint venture called "Rakuten AST" to build a direct-to-device satellite communications network in Japan.
Alliance Entertainment Holding Corporation filed a Form 8-K on November 10, 2026, reporting the voting results from its 2026 Annual Meeting of Stockholders held on November 5, 2026.
NET Power Inc. filed an 8-K on November 10, 2026, disclosing that its Board of Directors approved an amendment to the stock option held by President and Chief Operating Officer Marc Horstman, changing post-termination exercise rights effective November 4, 2026.
Aptera Motors Corp. filed a Form 8-K on November 10, 2026, disclosing the suspension and termination of its at-the-market offering prospectus and providing preliminary cash figures for the quarter ended September 30, 2026.
PepGen Inc. filed a current report on November 10, 2026, disclosing third quarter 2026 financial results and announcing positive Phase 2 FREEDOM2-DM1 data from its 10mg/kg multiple ascending dose cohort.
PDS Biotechnology Corporation filed a Form 8-K on November 10, 2026, disclosing that NantWorks exercised outstanding common stock warrants to purchase an aggregate of 17,699,115 shares of common stock at an exercise price of $0.22 per share, generating approximately $3.9 million in gross proceeds …
Paul J. Hastings submitted an initial statement of beneficial ownership with the SEC on November 10, 2026, in connection with an event date of November 3, 2026, disclosing his status as a director of Azora Therapeutics, Inc. (DE), listed on NASDAQ:AZR.